https://eureka.patsnap.com/resources/blog/rd-blog/quantitative-pcr-reference-gene-normalization-algorithm-patent-landscape/ · Patsnap · data cut-off 2026-10-27 · downloaded from the live page
Patent Landscape · Genomics & Bioinformatics

Quantitative PCR Reference Gene Normalization Patents

Dataset of 558 qPCR reference-gene normalization families: filer concentration, IPC splits and filing trend through 2026.

1,357
Published Records
558
Simple Patent Families
2%
Families Naming the Largest Filer
27%
In Force at Cut-off

1,357 published records collapse into 558 simple (DOCDB) families; the difference is the same invention filed in more than one country. THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV is named on 13 of the 558 patent families in scope. One patent family can name several filers, so these figures are not slices of a divided whole and do not add up. In force = 363 of 1,357 records still granted and maintained at the data cut-off; the rest are pending, withdrawn, refused or lapsed.

  • 558 simple patent families and 1,357 published records sit inside this search, with no date limit applied to the query string.
  • The largest single filer, The First Affiliated Hospital of Zhengzhou Univ, is named on 13 of the 558 families, a 2.3% share, while 47 of the 92 listed filers hold 2 or fewer families each.
  • C12Q carries the highest share of the technology split, appearing on 87.8% of the 558 families, ahead of C12N at 46.2%.
Check your own idea
Published byPatsnap Research··5 min readSourced from Patsnap Eureka
Overview

What this search covers

This dataset gathers records matching real-time or quantitative PCR together with reference gene, housekeeping gene or normalization language, combined with expression or quantification terms. No date limit was applied, so the 558 simple patent families and 1,357 published records in scope reflect whatever matches the search string across the full span the database holds, not a chosen window of years.

Readers should treat the filing-trend chart separately from this total: it shows a recent window only, and the two most recent years on it are still filling in as later-filed applications publish.

Families vs. records in scope
  1. THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV13
  2. CROP RES INST OF FUJIAN ACAD OF AGRI SCI11
  3. INST OF MEDICAL BIOLOGY CHINESE ACAD OF MEDICAL SCI10
  4. NANJING FORESTRY UNIV8
  5. ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES8
  6. GENENTECH INC7
  7. ZHEJIANG FORESTRY ACAD7
  8. STRETIFAER MOLEKYULAR PATOLODZHI GMBKH6
  9. BEIJING TONGREN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV6
  10. CAPITAL UNIVERSITY OF MEDICAL SCIENCES6

Ordered by volume only, not by importance or claim strength. Counted in simple (DOCDB) patent families, so one invention filed in several countries counts once. Names come from Patsnap's standardised assignee field as recorded on each document; subsidiaries and group companies are not merged. The icon before each name is read from the name itself (words such as University, Institute or Ltd); the data carries no organisation-type field, so treat it as a reading aid rather than a classification. Filings held by named individuals rather than organisations are removed where they can be identified (8 here); that identification is not exhaustive, so an individually held filing can still appear below. Either way those filings stay inside the totals above. This table shows the top 30 of the 92 filers returned for this search; the data endpoint returns at most 100 entities, so even that 92 is not the complete set of filers. A single family can name more than one filer, so these counts overlap and do not add up to the total.

Source: Patsnap Eureka. Assignee ranking and totals. Derived from one Patsnap search for Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape, covering all matching records regardless of filing date (the search string sets no date limit), retrieved 2026-10-27. Counts cover published records only and move as new filings publish.Run this in Eureka MCP
Data

Filing trend and technology composition

The figures below are drawn directly from the search result set: a filing trend counted in published records by earliest filing year, and an IPC breakdown counted in simple patent families.

Filing trend by earliest filing year

Published records ran from 28 in 2007 to a peak of 105 in 2018, with 20 recorded for 2026. The stretch from 2022 onward is still filling in as applications publish, so recent counts should not be read as a decline.

Filing trend by earliest filing year0306090120282007200920112013201520171052019202120232025202022 onwards are shaded as still filling in: a filing is only visible once it publishes, up to 30 months after filing.

Counted in published records by earliest filing year, not de-duplicated into families. A filing is counted in the year it was filed, but it only becomes visible after it publishes: roughly 18 months for most routes, and up to 30 months where a PCT application enters national phase. 2022 onwards are therefore still filling in and are shaded; no growth figure on this page uses them. Because this series counts documents rather than inventions, a rise can mean more inventions or the same inventions filed in more countries; this dataset cannot separate the two. This chart covers 2007-2026 (1,311 records); the 1,357 total quoted above includes earlier filings outside the window.

IPC subclass composition

C12Q (measuring and testing involving enzymes or DNA) appears on 87.8% of the 558 families, and C12N (microorganisms and genetic engineering) on 46.2%. Because one family can carry several IPC classes, these shares add up to more than 100%, and the chart carries 33 subclasses in total, of which only the two largest are discussed here.

IPC subclass compositionC12Q · Measuring & testing involving …49087.8%C12N · Microorganisms & genetic engin…25846.2%G01N · Material analysis & testing7012.5%G16B · Bioinformatics478.4%A61K · Medicinal preparations447.9%A61P · Therapeutic activity of compou…285.0%C07K · Peptides & proteins285.0%G06F · Electric digital data processi…183.2%Other9517.0%

Shares are the percentage of the 558 patent families in scope. One patent family can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from one Patsnap search for Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape, covering all matching records regardless of filing date (the search string sets no date limit), retrieved 2026-10-27. Counts cover published records only and move as new filings publish.

Go deeper on Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape with Eureka

This page is one run against one query. Ask Eureka your own question about quantitative pcr reference gene normalization algorithm patent landscape and every answer comes back with the patent numbers behind it.

Try Eureka
Record in Focus

A record from the result set

From the result set
US20240417786A12024-12-19

High Stokes shift fluorescence dyes for multiplex detection

QIAGEN GMBH

The abstract describes a fluorescence dye with a high Stokes shift large enough to skip at least one intermediate emission filter channel. It is used as a reference dye for non-droplet based dPCR systems to evaluate compartment filling levels, as a reference dye for fluorescence PCR normalization, or as a target-detection dye in multiplex PCR, with the compound bound to a probe or primer as a fluorescent label across dPCR, qPCR, RT-PCR and related formats.This is the first record returned under the database's default ordering, not a ranking by citations, grant status or breadth. Its number, assignee and filing date are shown alongside this summary.

US20240417786A1, patent drawing 1US20240417786A1, patent drawing 2
View full record

Selected as the first record the search returns under the database default order, then shown in full. It is not ranked by citations, claim breadth or commercial importance, and it is not a judgement about which filing in this space matters most.

Source: Patsnap Eureka. The first record the search returned, shown in full. Derived from one Patsnap search for Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape, covering all matching records regardless of filing date (the search string sets no date limit), retrieved 2026-10-27. Counts cover published records only and move as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

Reading the numbers

Three figures worth sitting with before drawing any conclusion about this field.

Legal status
27%
of 1,357 records

Granted and in force at retrieval

363 of the 1,357 published records (27%) were granted and still in force as of the 2026-10-27 retrieval date. The remainder are pending, withdrawn, refused, lapsed or not determinable, and that breakdown is not available on this page. This is a snapshot of legal status at one point in time, not a measure of filing quality.

Status at retrieval, not a success rate
Filer concentration
13 of 558
families, largest single filer

The largest single-row share is 2.3%

The First Affiliated Hospital of Zhengzhou Univ is named on 13 of the 558 simple patent families, a 2.3% share. 47 of the 92 listed filers hold 2 or fewer families each. Filer rows overlap because one family can name several filers, so rows cannot be summed into a combined share.

92 filers listed, ordered by volume only
Technology split
87.8%
of 558 families carry C12Q

C12Q and C12N carry the largest shares

C12Q (measuring and testing involving enzymes or DNA) appears on 490 of the 558 families (87.8%), and C12N (microorganisms and genetic engineering) on 258 (46.2%). Because a family can carry multiple IPC classes, these two shares overlap rather than add cleanly to a combined total.

Shares exceed 100% combined by design
Filing window
2007–2026
published records by earliest filing year

Peak year so far is 2018 at 105 records

Published records counted by earliest filing year ran from 28 in 2007 to a peak of 105 in 2018, with 20 recorded for 2026. The chart counts documents, not inventions, and the years from 2022 onward are still filling in as later filings publish.

Recent years understated by publication lag
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to quantitative pcr reference gene normalization algorithm patent landscape, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Derived observations on the same dataset. Derived from one Patsnap search for Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape, covering all matching records regardless of filing date (the search string sets no date limit), retrieved 2026-10-27. Counts cover published records only and move as new filings publish.Run this in Eureka MCP
What's Next

Where to take this

This page reports what one search returned. Turning that into a filing or freedom-to-operate decision needs tools built for claim-level reading.

Read claims, not just abstracts

A family count or an abstract summary cannot tell you what a granted claim requires. Pull the full claim set for any record before drawing conclusions about scope.

Explore Patsnap Eureka

Track filers beyond this snapshot

The 92 listed filers are ordered by volume only and are not rolled up to corporate group. Ongoing monitoring catches new filings and status changes as they publish.

Explore Patsnap Eureka
Source: Patsnap Eureka. Suggested next steps. No new data: every figure named here is one of those above. Derived from one Patsnap search for Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape, covering all matching records regardless of filing date (the search string sets no date limit), retrieved 2026-10-27. Counts cover published records only and move as new filings publish.Run this in Eureka MCP
FAQ

Common questions about this dataset

Answers are grounded in the same dataset. Derived from one Patsnap search for Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape, covering all matching records regardless of filing date (the search string sets no date limit), retrieved 2026-10-27. Counts cover published records only and move as new filings publish.Run this in Eureka MCP

Research Quantitative PCR Reference Gene Normalization Algorithm Patent Landscape in depth with Eureka

Go past this page: query the whole quantitative pcr reference gene normalization algorithm patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka
How this page was built, and what the numbers do and do not mean

Search. Every figure on this page comes from one Patsnap search, run once and not edited afterwards. This is the exact search string:

TAC:(("real time PCR" OR "quantitative PCR" OR qPCR) AND ("reference gene" OR "housekeeping gene" OR normalization) AND (expression OR quantification))

Reading the field codes: TAC searches the title, abstract and claims of each record, not the full description. The search string sets no date limit, so the scope is every matching record in the database regardless of when it was filed. It is not restricted to recent years. How this string was built matters for how far the counts can be pushed. It was generated in batch from a topic list rather than hand-crafted for this page, and the result set is not manually screened. A keyword search over title, abstract and claims both over-captures (unrelated filings that happen to use the same words) and under-captures (the same invention written in different words). This page cannot measure either effect, so read every figure here as what this particular string returned, not as what exists in the field. One subclass (C12Q) carries 87.8% of the patent families, so this search returned a classification-tight set.

What is being counted. Two different units appear on this page and they are not interchangeable. The filer list and the technology split are counted in simple (DOCDB) patent families: one invention counts once however many countries it was filed in. The total, the jurisdiction split and the filing-year chart are counted in published records: the same invention counts once per publication. For this search that is 1,357 records and 558 families. Record counts reward filing in many jurisdictions; family counts do not. Shares are only ever taken against a denominator in the same unit, and each one names it.

Who the filers are. Names come from Patsnap's standardised assignee field, as recorded on the documents themselves. They are not rolled up to corporate group: a parent and its subsidiaries appear as separate entries, and a portfolio acquired from another company stays under the name on the document unless the assignment is reflected there. This list is meant to carry organisations, not people. Filings held by a named individual are identified by matching the assignee against the inventors on the same search, and, for names written in Chinese, Japanese or Korean characters, by the name carrying no organisational suffix; those are removed from the list (8 of them here). Neither test is exhaustive: the inventor list it matches against is itself capped, and a personal name written in Latin script with no organisational wording in it cannot be told apart from a short company name by rule. So an individually held filing can still appear in the list. Those filings stay inside every total and share on this page either way, so the listed entries can add up to less than the total. A record shown in full further down still names its assignee exactly as the patent office records it, including where that is a person: that name is how the record is identified and checked. What is left out of the ranking is people as ranked entries, not people as cited sources. The table shows the top 30 of the 92 filers returned, ordered by count alone; the data endpoint returns at most 100 entities, so even that 92 is not every filer. One patent family can name several filers and each is counted separately, so these rows are not slices of a divided whole: adding them together over-counts, and this page deliberately publishes no combined "top five" share for that reason. See every filer, individuals included

Dates. The year chart counts by earliest filing year, not publication year. A filing only becomes visible once it publishes: roughly 18 months for most routes, and up to 30 months where a PCT application enters national phase. Measured across these pages, the year four back from today still holds only about 89% of its eventual count. 2022 onwards are therefore shaded on the chart as still filling in. The data behind this page was retrieved on 2026-10-27.

Legal status. "In force" counts documents whose legal status at retrieval was granted and maintained (363 of 1,357). Everything else is pending, withdrawn, refused, lapsed or not determinable, and those states are not broken out here because the underlying codes do not separate them cleanly. Legal status changes continuously and is reported per document, not per family. Get the status breakdown in Eureka

Classification. The technology split uses IPC subclasses (four characters, for example H01M). A single record usually carries several, so the shares add up to more than 100% and a record can appear in more than one bar. Subclass is a coarse grouping; it describes the field a record was classified into, not what the claims cover. Break the classes down to subgroup level

Who wrote the words. The tables, charts, counts, shares and patent numbers on this page are produced directly from the search result by a program; none of them are written or estimated by a language model. The surrounding prose, headings, FAQ answers and the answers in the question panel are drafted by a language model that is given those same figures and is not permitted to introduce others. Prose can still mis-describe a correct figure, so where the two disagree, the tables and charts are the record.

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries limitations that apply to every figure above. Recent filings are under-counted, because an application is not public until roughly 18 months after filing and database loading adds further delay. The search string defines and constrains everything shown: records that use different terminology, or that sit outside the fields searched, are absent and cannot be counted. Applicant names, classification codes, legal-status codes and citation records are taken as recorded and may contain errors, duplicates, omissions or stale entries. Ordering by volume is not a measure of quality, scope, enforceability or commercial value, and a larger portfolio is not a stronger one. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, validity or infringement search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. No attorney-client relationship is created by it. Any patent, commercial, or strategic decision should be verified independently against the primary records and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

The question panel. The answers behind the suggested questions on this page were written when the page was generated, not in response to your click. The progress steps that play before an answer appears are an animation of how that analysis was done; nothing is being searched or computed at that moment. Typing your own question instead opens Patsnap Eureka, which does run it live.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.